TrialThe journal of prevention of Alzheimer's disease2025

A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study).

Laura Forcano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.